Cathy McMorris Rodgers - the Chair of the House Energy and Commerce Committee | Official U.S. House headshot
Cathy McMorris Rodgers - the Chair of the House Energy and Commerce Committee | Official U.S. House headshot
House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) have announced a subcommittee hearing titled “Oversight of 340B Drug Pricing Program.”
“It’s important that we preserve patients’ access to important and life-saving drugs. We must explore how the 340B program is working to ensure it aligns with how the program was intended to function,” said Chairs Rodgers and Griffith. “This hearing will give Members an opportunity to hear from industry experts about how the 340B program is working and, if necessary, how it could be improved.”
The hearing aims to address recent trends and developments in the 340B drug pricing program.
Details for the hearing are as follows:
- **What:** A subcommittee oversight hearing on the 340B drug pricing program.
- **Date:** Tuesday, June 4, 2024
- **Time:** 10:30 AM ET
- **Location:** 2322 Rayburn House Office Building
Witnesses for the hearing will be announced later and will attend by invitation only. The session will be open to both the public and press, with live streaming available online at https://energycommerce.house.gov/.
For further information regarding the hearing, contact Lauren Kennedy at Lauren.Kennedy@mail.house.gov. Press inquiries should be directed to Christopher Krepich at Christopher.Krepich@mail.house.gov.
Alerts Sign-up